✦ LIBER ✦

Interferon Inhibits Progression of Liver Fibrosis and Reduces the Risk of Hepatocarcinogenesis in Patients with Chronic Hepatitis C: A Retrospective Multicenter Analysis of 652 Patients

✍ Scribed by Mitsuhiro Takimoto; Shogo Ohkoshi; Takafumi Ichida; Yasuo Takeda; Minoru Nomoto; Hitoshi Asakura; Akira Naito; Shigeki Mori; Kojiro Hata; Kentaro Igarashi; Hidenori Hara; Hironobu Ohta; Kenji Soga; Toshiaki Watanabe; Tomoteru Kamimura

Book ID: 110320432
Publisher: Springer US
Year: 2002
Tongue: English
Weight: 72 KB
Volume: 47
Category: Article
ISSN: 0163-2116
DOI: 10.1023/a:1013244326874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rates and risk factors of liver fibrosis

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C

✍ Thierry Poynard; Vlad Ratziu; Frédéric Charlotte; Zachary Goodman; John McHutchi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 365 KB

690 SUPPRESSION OF ALPHA-FETOPROTEIN BY

690 SUPPRESSION OF ALPHA-FETOPROTEIN BY INTERFERON THERAPY REDUCES THE RISK OF HEPATOCARCINOGENESIS IN PATIENTS WITH CHRONIC HEPATITIS C

✍ Y. Asahina; K. Tsuchiya; M. Muraoka; K. Tanaka; Y. Suzuki; N. Tamaki; Y. Hoshiok 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Impact of Interferon Alfa-2b and Ribavir

Impact of Interferon Alfa-2b and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis C

✍ Thierry Poynard; John McHutchison; Gary L. Davis; Rafael Esteban-Mur; Zachary Go 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Quantitative analysis of liver fibrosis

Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy

✍ Isao Sakaida; Atsuko Nagatomi; Koji Hironaka; Koichi Uchida; Kiwamu Okita 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 968 KB

Su1026 Statin Use Reduces Risk of Progre

Su1026 Statin Use Reduces Risk of Progression of Liver Fibrosis, Among Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial

✍ Simon, Tracey G.; King, Lindsay Y.; Zheng, Hui; Chung, Raymond T. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 374 KB

YKL-40 genetic polymorphisms and the ris

YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C

✍ Robert J. Fontana; Heather J. Litman; Jules L. Dienstag; Herbert L. Bonkovsky; G 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB